Description

B7-33 Peptide Vials

Introduction

B7-33 Vials represent a cutting-edge research product designed exclusively for scientific investigation and experimentation. This innovative formulation, synthesized through rigorous laboratory processes, is strictly intended for research purposes and is not intended for human consumption.

Key Characteristics

B7-33 Vials exhibit unique chemical properties, carefully curated for precision in laboratory studies. The formulation is characterized by its purity, stability, and reproducibility, ensuring reliable results in diverse research settings.

Research Applications

The versatility of B7-33 Vials makes them applicable across various fields of scientific exploration. Researchers can utilize these vials to delve into complex biological processes, making it an invaluable tool in advancing our understanding of specific cellular and molecular mechanisms.

Research Benefits

B7-33 and Preeclampsia Phenotype

B7-33 demonstrates potential significance in the context of preeclampsia. Research studies have explored the relationship between B7-33 and the modulation of factors contributing to the preeclampsia phenotype. These studies suggest a promising avenue for further investigation into the underlying mechanisms and potential therapeutic implications.

B7-33 and Anti-Fibrotic Properties

Research on B7-33 has revealed its anti-fibrotic properties, as documented in these investigations pointing toward the potential of B7-33 in mitigating fibrotic processes within biological systems. This property opens avenues for research in conditions where fibrosis plays a pivotal role.

B7-33 and Blood Vessel

Studies shed light on the impact of B7-33 on blood vessel physiology. The research indicates that B7-33 may influence key factors related to blood vessel function. Further exploration in this area could provide valuable insights into cardiovascular health and related disorders.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References:

1. Hossain MA, Kocan M, Yao ST, Royce SG, Nair VB, Siwek C, Patil NA, Harrison IP, Rosengren KJ, Selemidis S, Summers RJ, Wade JD, Bathgate RAD, Samuel CS. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1. Chem Sci. 2016 Jun 1;7(6):3805-3819. doi: 10.1039/c5sc04754d. Epub 2016 Feb 26. PMID: 30155023; PMCID: PMC6013806. [Read More]
2. Marshall SA, O’Sullivan K, Ng HH, Bathgate RAD, Parry LJ, Hossain MA, Leo CH. B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin). Eur J Pharmacol. 2017 Jul 15;807:190-197. doi: 10.1016/j.ejphar.2017.05.005. Epub 2017 May 3. PMID: 28478069. [Read More]